Ignite Creation Date:
2024-05-05 @ 4:40 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00292929
Status:
COMPLETED
Last Update Posted:
2016-10-26
First Post:
2006-02-14
Brief Title:
Study of the Safety of Intravenous Artesunate
Sponsor:
US Army Medical Research and Development Command
Organization:
US Army Medical Research and Development Command
Study Overview
Official Title:
A Phase 1 Randomized Double-Blind Placebo-Controlled Dose Escalation Study of the Safety Tolerability and Pharmacokinetics of Single Intravenous Doses of Artesunate Administered to Healthy Subjects
Status:
COMPLETED
Status Verified Date:
2007-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to establish the safety tolerability and pharmacokinetics of a single dose of the antimalarial drug artesunate
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| HSRRB A-13276 | None | None | None |
| USUHS G183RW | None | None | None |